Atenolol News and Research

RSS
Atenolol is a ß1 receptor specific antagonist, a drug belonging to the group of ß-blockers, a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases and conditions such as hypertension, coronary heart disease, arrhythmias, angina (chest pain) and to treat and reduce the risk of heart complications following myocardial infarction (heart attack)
Blood pressure treatment could cut risk of strokes and heart attacks

Blood pressure treatment could cut risk of strokes and heart attacks

Excellent news for the many people who suffer from high blood pressure

Excellent news for the many people who suffer from high blood pressure

Atenolol beta-blocker may not be effective in reducing heart attacks

Atenolol beta-blocker may not be effective in reducing heart attacks

Anti-hypertensive drug clonidine before non-cardiac surgery reduces risk of complications due to inadequate blood flow to the heart

Anti-hypertensive drug clonidine before non-cardiac surgery reduces risk of complications due to inadequate blood flow to the heart

Regular use of beta-agonist drugs for asthma could be endangering their patients

Regular use of beta-agonist drugs for asthma could be endangering their patients